UBS Group Begins Coverage on MorphoSys (NASDAQ:MOR)

UBS Group started coverage on shares of MorphoSys (NASDAQ:MOR – Get Rating) in a research note published on Wednesday, The Fly reports. The brokerage issued a buy rating on the stock. MorphoSys Price Performance NASDAQ:MOR opened at $6.58 on Wednesday. The stock has a market cap of $901.00 million, a P/E ratio of -8.12 and […]

Related Keywords

,Nasdaq ,Ubs Group ,Virtu Financial ,Susquehanna International Group ,Citadel Advisors ,Morphosys Company Profile ,Sigma Securities ,Get Rating ,International Group ,Two Sigma Securities ,Morphosys Daily ,Morphosys ,Nasdaq Mor ,Humor ,Medical ,Initiated Coverage ,Ubs Group Ag ,